Search

Your search keyword '"Aldona Kowalska"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Aldona Kowalska" Remove constraint Author: "Aldona Kowalska" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
143 results on '"Aldona Kowalska"'

Search Results

2. Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine

3. Genotoxicity Associated with 131I and 99mTc Exposure in Nuclear Medicine Staff: A Physical and Biological Monitoring Study

4. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity

5. Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.

6. Late-Onset Medullary Thyroid Cancer in a Patient with a Germline RET Codon C634R Mutation

7. Diagnosis of thyroid tumours in Świętokrzyskie Province in Poland with respect to the regulations provided in the new oncological package

8. Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine

9. Repeated nondiagnostic result of thyroid fine-needle aspiration biopsy

10. Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis

11. Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A Case Report

12. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

13. Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.

14. The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

15. 99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.

16. The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.

21. DUONEN multicenter study - personalized PRRT treatment with 177Lu- or 177Lu/90Y-DOTA-TATE in patients with neuroendocrine tumors based on individual dosimetry

22. Colorectal neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita grubego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]

23. Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne jelita cienkiego i wyrostka robaczkowego — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

24. Gastroduodenal neuroendocrine neoplasms including gastrinoma — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma — uaktualnione zasady postępowania (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

25. Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]

26. Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]

27. Basics of prevention and management of iodine-based contrast media-induced thyroid dysfunction - position paper by the Polish Society of Endocrinology

28. A Significance of Concomitant BRAF

29. Genotoxicity Associated with

30. Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]

31. Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?

33. Occurrence of Arrhythmias in Women with Thyroid Cancer Receiving Suppressive Doses of Levothyroxine

34. Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer

36. Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

37. Incidence of the

38. Are molecular tests necessary to diagnose NIFTP?

39. Unusual case of radioactive iodine induced Graves disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma

40. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity

41. Telomeres and telomerase in oncogenesis

42. Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

43. The current state and future perspectives of high intensity focused ultrasound (HIFU) ablation for benign thyroid nodules

44. Rekomendacje Polskich Towarzystw Naukowych 'Diagnostyka i leczenie raka tarczycy'. Aktualizacja na rok 2018

46. Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy

47. Measurement of 131I activity in air indoor Polish nuclear medical hospital as a tool for an internal dose assessment

48. Diagnosis of thyroid tumours in Świętokrzyskie Province in Poland with respect to the regulations provided in the new oncological package

49. Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine

50. Immunohistochemistry cannot replace DNA analysis for evaluation ofBRAFV600E mutations in papillary thyroid carcinoma

Catalog

Books, media, physical & digital resources